BioCardia, Inc. (BCDAD) financial statements (2020 and earlier)

Company profile

Business Address 125 SHOREWAY ROAD
SAN CARLOS, CA 94070
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments951321141413
Cash and cash equivalents951321141413
Receivables0000   
Inventory, net of allowances, customer advances and progress billings0000  
Inventory0000   
Prepaid expense 000   
Other undisclosed current assets0      
Total current assets:961322141413
Noncurrent Assets
Operating lease, right-of-use asset1
Property, plant and equipment0000   
Other noncurrent assets0000   
Total noncurrent assets:1000   
Other undisclosed assets    000
TOTAL ASSETS:1161422141413
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1211000
Accounts payable1111   
Accrued liabilities0011   
Other undisclosed accounts payable and accrued liabilities    000
Deferred revenue0
Debt1      
Deferred revenue and credits00   
Customer advances and deposits0   
Contract with customer, liability0
Other undisclosed current liabilities2110   
Total current liabilities:4321000
Noncurrent Liabilities
Long-term debt and lease obligation1      
Operating lease, liability1
Liabilities, other than long-term debt1000   
Deferred revenue and credits00   
Deferred revenue1
Deferred rent credit 0
Total noncurrent liabilities:1000   
Total liabilities:5322000
Stockholders' equity
Stockholders' equity attributable to parent, including:541121141413
Common stock0000000
Additional paid in capital103908480262626
Accumulated deficit(98)(86)(72)(60)(12)(12)(13)
Other undisclosed stockholders' equity attributable to parent      0
Total stockholders' equity:541121141413
TOTAL LIABILITIES AND EQUITY:1161422141413

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues1101100
Revenue, net01100
Other operating income00     
Cost of revenue
(Cost of Goods and Services Sold)
(0)(1)(1)(1)   
Gross profit:00(0)(0)100
Operating expenses(14)(14)(12)(7)(0)(0)(0)
Other operating income, net     00
Other undisclosed operating loss     (0)(0)
Operating income (loss):(14)(14)(12)(8)000
Nonoperating income (expense)(1)00(3)   
Interest and debt expense(1)  (2)   
Income (loss) from continuing operations before equity method investments, income taxes:(15)(14)(12)(12)000
Other undisclosed income from continuing operations before income taxes    000
Net income (loss):(15)(14)(12)(12)000
Other undisclosed net income attributable to parent1  2   
Net income (loss) available to common stockholders, diluted:(15)(14)(12)(10)000

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(15)(14)(12)(12)000
Comprehensive income (loss), net of tax, attributable to parent:(15)(14)(12)(12)000

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: